794 related articles for article (PubMed ID: 32853412)
1. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
[TBL] [Abstract][Full Text] [Related]
2. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration.
Long M; Zhou Z; Wei X; Lin Q; Qiu M; Zhou Y; Chen P; Jiang Y; Wen Q; Liu Y; Li R; Zhou X; Yu H
Front Immunol; 2022; 13():1023349. PubMed ID: 36353638
[TBL] [Abstract][Full Text] [Related]
3. Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.
Qin P; Zhang M; Liu X; Dong Z
J Healthc Eng; 2021; 2021():3761858. PubMed ID: 34745496
[TBL] [Abstract][Full Text] [Related]
4. Exploration of prognostic index based on immune-related genes in patients with liver hepatocellular carcinoma.
Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32579175
[TBL] [Abstract][Full Text] [Related]
5. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.
Liu Z; Jiao D; Liu L; Zhou X; Yao Y; Li Z; Li J; Chen J; Lei Q; Han X
Medicine (Baltimore); 2021 Mar; 100(10):e24683. PubMed ID: 33725827
[TBL] [Abstract][Full Text] [Related]
7. A novel immune-related genes prognosis biomarker for hepatocellular carcinoma.
Wang K; Chen X; Jin C; Mo J; Jiang H; Yi B; Chen X
Aging (Albany NY); 2020 Nov; 13(1):675-693. PubMed ID: 33260154
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients.
Hu B; Yang XB; Sang XT
Int Immunopharmacol; 2021 Jan; 90():107164. PubMed ID: 33172741
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
[TBL] [Abstract][Full Text] [Related]
10. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma.
Chen H; Li Y; Xiao SY; Guo J
BMC Cancer; 2021 Mar; 21(1):278. PubMed ID: 33726698
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
[TBL] [Abstract][Full Text] [Related]
12. A New Inflammation-Related Risk Model for Predicting Hepatocellular Carcinoma Prognosis.
Xing M; Li J
Biomed Res Int; 2022; 2022():5396128. PubMed ID: 35572724
[TBL] [Abstract][Full Text] [Related]
13. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
14. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
15. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients.
Ye D; Liu Y; Li G; Sun B; Peng J; Xu Q
Front Oncol; 2021; 11():766072. PubMed ID: 34868990
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma.
Tang X; Ren X; Huang T; Miao Y; Ha W; Li Z; Yang L; Mi D
Mediators Inflamm; 2023; 2023():3951940. PubMed ID: 37124062
[TBL] [Abstract][Full Text] [Related]
17. TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients.
He G; Fu S; Li Y; Li T; Mei P; Feng L; Cai L; Cheng Y; Zhou C; Tang Y; Huang W; Liu H; Cen B; Pan M; Gao Y
Aging (Albany NY); 2020 Nov; 12(21):21544-21558. PubMed ID: 33177245
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
[TBL] [Abstract][Full Text] [Related]
19. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
20. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
